Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
29
ELV Quote, Financials, Valuation and Earnings
Last price:
$373.07
Seasonality move
:
3.48%
Day range:
$367.73 - $373.28
52-week range:
$362.21 - $567.26
Dividend yield:
1.75%
P/E ratio:
13.60x
P/S ratio:
0.50x
P/B ratio:
1.98x
Volume:
467.4K
Avg. volume:
2M
1-year change:
-20.07%
Market cap:
$86.5B
Revenue:
$171.3B
EPS (TTM):
$27.43
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ELV
Elevance Health
|
$43.1B | $9.65 | 4.45% | 6.97% | $508.08 |
|
CI
The Cigna Group
|
$59.6B | $7.25 | 23.39% | 124.1% | $395.73 |
|
CNC
Centene
|
$37.9B | $1.41 | -1.23% | 603.74% | $79.39 |
|
CVS
CVS Health
|
$92.7B | $1.45 | 3.57% | -24.22% | $66.26 |
|
MOH
Molina Healthcare
|
$9.9B | $5.94 | 14.6% | 58.81% | $360.77 |
|
UNH
UnitedHealth Group
|
$99.3B | $7.03 | 9.14% | 15.66% | $636.05 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ELV
Elevance Health
|
$372.94 | $508.08 | $86.5B | 13.60x | $1.63 | 1.75% | 0.50x |
|
CI
The Cigna Group
|
$280.06 | $395.73 | $77.9B | 26.42x | $1.40 | 2% | 0.35x |
|
CNC
Centene
|
$60.83 | $79.39 | $30.7B | 10.56x | $0.00 | 0% | 0.20x |
|
CVS
CVS Health
|
$44.25 | $66.26 | $55.7B | 11.23x | $0.67 | 6.01% | 0.15x |
|
MOH
Molina Healthcare
|
$295.19 | $360.77 | $16.9B | 14.99x | $0.00 | 0% | 0.44x |
|
UNH
UnitedHealth Group
|
$506.10 | $636.05 | $465.8B | 32.97x | $2.10 | 1.62% | 1.21x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ELV
Elevance Health
|
38.28% | 0.830 | 22.49% | 2.14x |
|
CI
The Cigna Group
|
43.8% | 1.317 | 33.76% | 0.80x |
|
CNC
Centene
|
39.2% | 0.813 | 45.73% | 1.05x |
|
CVS
CVS Health
|
46.65% | 1.692 | 82.68% | 0.54x |
|
MOH
Molina Healthcare
|
32.84% | 1.082 | 11.87% | 1.50x |
|
UNH
UnitedHealth Group
|
45.21% | 0.337 | 14.19% | 0.83x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health
|
-- | -- | 9.55% | 15.67% | 3.71% | $2.3B |
|
CI
The Cigna Group
|
-- | -- | 4.03% | 6.99% | 2.5% | -$353M |
|
CNC
Centene
|
$4B | $665M | 6.9% | 11.5% | 2.61% | -$1.1B |
|
CVS
CVS Health
|
$12.6B | $2B | 3.61% | 6.68% | 0.9% | -$1.4B |
|
MOH
Molina Healthcare
|
$1.2B | $467M | 17.2% | 25.77% | 4.52% | $838M |
|
UNH
UnitedHealth Group
|
$21.4B | $7.1B | 8.46% | 14.51% | 8.76% | $13B |
Elevance Health vs. Competitors
-
Which has Higher Returns ELV or CI?
The Cigna Group has a net margin of 2.25% compared to Elevance Health's net margin of 1.18%. Elevance Health's return on equity of 15.67% beat The Cigna Group's return on equity of 6.99%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $4.36 $71B CIThe Cigna Group-- $2.63 $75.1B -
What do Analysts Say About ELV or CI?
Elevance Health has a consensus price target of $508.08, signalling upside risk potential of 36.24%. On the other hand The Cigna Group has an analysts' consensus of $395.73 which suggests that it could grow by 41.3%. Given that The Cigna Group has higher upside potential than Elevance Health, analysts believe The Cigna Group is more attractive than Elevance Health.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health14 4 0 CIThe Cigna Group14 4 0 -
Is ELV or CI More Risky?
Elevance Health has a beta of 0.828, which suggesting that the stock is 17.228% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.504, suggesting its less volatile than the S&P 500 by 49.631%.
-
Which is a Better Dividend Stock ELV or CI?
Elevance Health has a quarterly dividend of $1.63 per share corresponding to a yield of 1.75%. The Cigna Group offers a yield of 2% to investors and pays a quarterly dividend of $1.40 per share. Elevance Health pays 23.3% of its earnings as a dividend. The Cigna Group pays out 28.08% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CI?
Elevance Health quarterly revenues are $45.1B, which are smaller than The Cigna Group quarterly revenues of $62.8B. Elevance Health's net income of $1B is higher than The Cigna Group's net income of $739M. Notably, Elevance Health's price-to-earnings ratio is 13.60x while The Cigna Group's PE ratio is 26.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.50x versus 0.35x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.50x 13.60x $45.1B $1B CIThe Cigna Group0.35x 26.42x $62.8B $739M
-
Which has Higher Returns ELV or CNC?
Centene has a net margin of 2.25% compared to Elevance Health's net margin of 1.7%. Elevance Health's return on equity of 15.67% beat Centene's return on equity of 11.5%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $4.36 $71B CNCCentene9.6% $1.36 $45B -
What do Analysts Say About ELV or CNC?
Elevance Health has a consensus price target of $508.08, signalling upside risk potential of 36.24%. On the other hand Centene has an analysts' consensus of $79.39 which suggests that it could grow by 30.52%. Given that Elevance Health has higher upside potential than Centene, analysts believe Elevance Health is more attractive than Centene.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health14 4 0 CNCCentene8 6 1 -
Is ELV or CNC More Risky?
Elevance Health has a beta of 0.828, which suggesting that the stock is 17.228% less volatile than S&P 500. In comparison Centene has a beta of 0.457, suggesting its less volatile than the S&P 500 by 54.321%.
-
Which is a Better Dividend Stock ELV or CNC?
Elevance Health has a quarterly dividend of $1.63 per share corresponding to a yield of 1.75%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 23.3% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CNC?
Elevance Health quarterly revenues are $45.1B, which are larger than Centene quarterly revenues of $42B. Elevance Health's net income of $1B is higher than Centene's net income of $713M. Notably, Elevance Health's price-to-earnings ratio is 13.60x while Centene's PE ratio is 10.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.50x versus 0.20x for Centene. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.50x 13.60x $45.1B $1B CNCCentene0.20x 10.56x $42B $713M
-
Which has Higher Returns ELV or CVS?
CVS Health has a net margin of 2.25% compared to Elevance Health's net margin of 0.09%. Elevance Health's return on equity of 15.67% beat CVS Health's return on equity of 6.68%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $4.36 $71B CVSCVS Health13.16% $0.07 $140.6B -
What do Analysts Say About ELV or CVS?
Elevance Health has a consensus price target of $508.08, signalling upside risk potential of 36.24%. On the other hand CVS Health has an analysts' consensus of $66.26 which suggests that it could grow by 49.74%. Given that CVS Health has higher upside potential than Elevance Health, analysts believe CVS Health is more attractive than Elevance Health.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health14 4 0 CVSCVS Health12 10 0 -
Is ELV or CVS More Risky?
Elevance Health has a beta of 0.828, which suggesting that the stock is 17.228% less volatile than S&P 500. In comparison CVS Health has a beta of 0.541, suggesting its less volatile than the S&P 500 by 45.901%.
-
Which is a Better Dividend Stock ELV or CVS?
Elevance Health has a quarterly dividend of $1.63 per share corresponding to a yield of 1.75%. CVS Health offers a yield of 6.01% to investors and pays a quarterly dividend of $0.67 per share. Elevance Health pays 23.3% of its earnings as a dividend. CVS Health pays out 37.54% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CVS?
Elevance Health quarterly revenues are $45.1B, which are smaller than CVS Health quarterly revenues of $95.4B. Elevance Health's net income of $1B is higher than CVS Health's net income of $87M. Notably, Elevance Health's price-to-earnings ratio is 13.60x while CVS Health's PE ratio is 11.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.50x versus 0.15x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.50x 13.60x $45.1B $1B CVSCVS Health0.15x 11.23x $95.4B $87M
-
Which has Higher Returns ELV or MOH?
Molina Healthcare has a net margin of 2.25% compared to Elevance Health's net margin of 3.15%. Elevance Health's return on equity of 15.67% beat Molina Healthcare's return on equity of 25.77%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $4.36 $71B MOHMolina Healthcare11.5% $5.65 $7.1B -
What do Analysts Say About ELV or MOH?
Elevance Health has a consensus price target of $508.08, signalling upside risk potential of 36.24%. On the other hand Molina Healthcare has an analysts' consensus of $360.77 which suggests that it could grow by 22.22%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health14 4 0 MOHMolina Healthcare5 8 0 -
Is ELV or MOH More Risky?
Elevance Health has a beta of 0.828, which suggesting that the stock is 17.228% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.536, suggesting its less volatile than the S&P 500 by 46.386%.
-
Which is a Better Dividend Stock ELV or MOH?
Elevance Health has a quarterly dividend of $1.63 per share corresponding to a yield of 1.75%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 23.3% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or MOH?
Elevance Health quarterly revenues are $45.1B, which are larger than Molina Healthcare quarterly revenues of $10.3B. Elevance Health's net income of $1B is higher than Molina Healthcare's net income of $326M. Notably, Elevance Health's price-to-earnings ratio is 13.60x while Molina Healthcare's PE ratio is 14.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.50x versus 0.44x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.50x 13.60x $45.1B $1B MOHMolina Healthcare0.44x 14.99x $10.3B $326M
-
Which has Higher Returns ELV or UNH?
UnitedHealth Group has a net margin of 2.25% compared to Elevance Health's net margin of 6.11%. Elevance Health's return on equity of 15.67% beat UnitedHealth Group's return on equity of 14.51%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $4.36 $71B UNHUnitedHealth Group21.56% $6.51 $182.5B -
What do Analysts Say About ELV or UNH?
Elevance Health has a consensus price target of $508.08, signalling upside risk potential of 36.24%. On the other hand UnitedHealth Group has an analysts' consensus of $636.05 which suggests that it could grow by 25.68%. Given that Elevance Health has higher upside potential than UnitedHealth Group, analysts believe Elevance Health is more attractive than UnitedHealth Group.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health14 4 0 UNHUnitedHealth Group18 3 0 -
Is ELV or UNH More Risky?
Elevance Health has a beta of 0.828, which suggesting that the stock is 17.228% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.583, suggesting its less volatile than the S&P 500 by 41.67%.
-
Which is a Better Dividend Stock ELV or UNH?
Elevance Health has a quarterly dividend of $1.63 per share corresponding to a yield of 1.75%. UnitedHealth Group offers a yield of 1.62% to investors and pays a quarterly dividend of $2.10 per share. Elevance Health pays 23.3% of its earnings as a dividend. UnitedHealth Group pays out 30.21% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or UNH?
Elevance Health quarterly revenues are $45.1B, which are smaller than UnitedHealth Group quarterly revenues of $99.2B. Elevance Health's net income of $1B is lower than UnitedHealth Group's net income of $6.1B. Notably, Elevance Health's price-to-earnings ratio is 13.60x while UnitedHealth Group's PE ratio is 32.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.50x versus 1.21x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.50x 13.60x $45.1B $1B UNHUnitedHealth Group1.21x 32.97x $99.2B $6.1B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
